Algernon Pharmaceuticals has officially changed its name to Algernon Health, marking a significant shift in its corporate strategy. The new name will be reflected in trading...
A recent study conducted by researchers at University College London reveals that up to 33% of Alzheimer’s disease cases could potentially be avoided by mitigating specific...
UPDATE: A shocking report reveals that dementia cases in Canada are set to exceed 1 million by 2030, with current estimates indicating that approximately 750,000 Canadians...
Research indicates that cats experiencing dementia exhibit brain changes similar to those seen in humans with Alzheimer’s disease. A recent study reveals that the accumulation of...
Alberta’s healthcare system is at a critical juncture as new therapies for Alzheimer’s disease emerge, presenting both an opportunity and a challenge for patient care. For...
